Skip to main content

Ask your doctor about Enterra® Therapy

Let’s take back your seat at the table

If you’re ready to take the next step in your journey to relief from the chronic nausea and vomiting symptoms of gastroparesis, it may be time to ask your doctor about Enterra® Therapy.

Not sure where to start? The Enterra Therapy Discussion Guide provides tools to help you prepare for your appointment, next steps, and more.

Get one-on-one support

Do you still have questions about Enterra Therapy?

Speak to an Enterra Medical Patient Liaison—trained professionals with healthcare experience who can answer your questions and give you the resources you need to find out if Enterra Therapy is right for you.*

Monday through Friday
8am to 5pm EST.

Schedule a call with an
Enterra Medical Patient Liaison.

Looking for educational resources?

No matter where you might be in your gastroparesis journey, we’ve got resources available to help you understand and navigate diagnosis and consider treatment options, including Enterra Therapy.

You’re a potential candidate for Enterra Therapy if:

  • you have gastroparesis due to diabetes or an idiopathic (unknown) cause
  • you are 18-70 years old
  • you have chronic nausea and vomiting that has not responded to medication

The next step is talking to your doctor about whether Enterra Therapy is right for you.

*The information provided on this website is for general educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always talk to your doctor about the best treatment options for your individual situation.

MKT-D-0003, Rev T


Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.


Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?